Gold Reserve Ltd. (GDRZF)
OTCMKTS · Delayed Price · Currency is USD
3.960
+0.020 (0.51%)
Aug 8, 2025, 3:15 PM EDT
Revance Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 40.93 | 42.82 | 8.53 | 15.38 | 49.12 | 57.42 | Upgrade |
Short-Term Investments | 32.95 | 34.17 | 29.36 | 27.5 | - | - | Upgrade |
Trading Asset Securities | 1.48 | 1.42 | 1.18 | 0.1 | 0.11 | 0.08 | Upgrade |
Cash & Short-Term Investments | 75.36 | 78.42 | 39.07 | 42.98 | 49.22 | 57.5 | Upgrade |
Cash Growth | 96.69% | 100.74% | -9.10% | -12.69% | -14.39% | -7.26% | Upgrade |
Other Receivables | - | - | - | 8.09 | 8.68 | 8.68 | Upgrade |
Receivables | - | - | - | 8.09 | 8.68 | 8.68 | Upgrade |
Prepaid Expenses | 0.16 | 0.26 | 0.29 | 0.46 | 0.51 | 0.57 | Upgrade |
Total Current Assets | 75.52 | 78.68 | 39.36 | 51.53 | 58.41 | 66.76 | Upgrade |
Property, Plant & Equipment | 0.36 | 0.36 | 0.38 | 1.42 | 2.23 | 2.68 | Upgrade |
Total Assets | 75.88 | 79.04 | 39.74 | 52.94 | 60.64 | 69.44 | Upgrade |
Accounts Payable | 8.15 | 2.32 | 0.71 | 0.65 | 0.47 | 0.78 | Upgrade |
Accrued Expenses | - | 1 | 0.74 | 0.53 | - | - | Upgrade |
Current Portion of Leases | - | - | - | - | 0.08 | 0.09 | Upgrade |
Current Income Taxes Payable | 10.86 | 10.62 | 9.71 | - | - | - | Upgrade |
Other Current Liabilities | - | - | - | 0.17 | 0.06 | 0.06 | Upgrade |
Total Current Liabilities | 19.01 | 13.94 | 11.16 | 1.35 | 0.61 | 0.93 | Upgrade |
Long-Term Leases | - | - | - | - | - | 0.08 | Upgrade |
Total Liabilities | 19.01 | 13.94 | 11.16 | 1.35 | 0.61 | 1.01 | Upgrade |
Common Stock | 1.13 | 1.13 | 302.68 | 302.68 | 302.68 | 302.47 | Upgrade |
Additional Paid-In Capital | 372.35 | 372.35 | 20.63 | 20.63 | 20.63 | 20.63 | Upgrade |
Retained Earnings | -342.22 | -333.58 | -318.39 | -295.27 | -286.68 | -276.08 | Upgrade |
Comprehensive Income & Other | 25.61 | 25.2 | 23.66 | 23.56 | 23.4 | 21.41 | Upgrade |
Shareholders' Equity | 56.88 | 65.1 | 28.58 | 51.59 | 60.03 | 68.42 | Upgrade |
Total Liabilities & Equity | 75.88 | 79.04 | 39.74 | 52.94 | 60.64 | 69.44 | Upgrade |
Total Debt | - | - | - | - | 0.08 | 0.17 | Upgrade |
Net Cash (Debt) | 75.36 | 78.42 | 39.07 | 42.98 | 49.15 | 57.33 | Upgrade |
Net Cash Growth | 96.69% | 100.74% | -9.10% | -12.55% | -14.27% | -7.15% | Upgrade |
Net Cash Per Share | 0.69 | 0.74 | 0.39 | 0.43 | 0.49 | 0.58 | Upgrade |
Filing Date Shares Outstanding | 113.04 | 113.04 | 99.67 | 99.55 | 99.55 | 99.4 | Upgrade |
Total Common Shares Outstanding | 113.04 | 113.04 | 99.55 | 99.55 | 99.55 | 99.4 | Upgrade |
Working Capital | 56.51 | 64.73 | 28.19 | 50.18 | 57.8 | 65.82 | Upgrade |
Book Value Per Share | 0.50 | 0.58 | 0.29 | 0.52 | 0.60 | 0.69 | Upgrade |
Tangible Book Value | 56.88 | 65.1 | 28.58 | 51.59 | 60.03 | 68.42 | Upgrade |
Tangible Book Value Per Share | 0.50 | 0.58 | 0.29 | 0.52 | 0.60 | 0.69 | Upgrade |
Machinery | 0.33 | 0.33 | 0.75 | 1.72 | 2.35 | 2.61 | Upgrade |
Leasehold Improvements | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.